Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.980
0.00 (0.00%)
May 13, 2025, 3:00 PM CST

Kangmei Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
13.1212.08102.52-2,6887,918-31,085
Upgrade
Depreciation & Amortization
339.99339.99340.48365.69603.22644.83
Upgrade
Other Amortization
33.4233.4228.1927.7335.19133.15
Upgrade
Loss (Gain) From Sale of Assets
-39.47-39.47-19.61-0.98-64.0144.96
Upgrade
Asset Writedown & Restructuring Costs
145.09145.0999.97307.462,6431,508
Upgrade
Loss (Gain) From Sale of Investments
-59.18-59.18-44.4-0.75-188.794.59
Upgrade
Provision & Write-off of Bad Debts
---238.47213.411,1921,003
Upgrade
Other Operating Activities
785.4322.52196.51278.142,57726,027
Upgrade
Change in Accounts Receivable
-502.64-502.64215.15-339.53-746.883,130
Upgrade
Change in Inventory
-34.32-34.32-93.01-253.621,6661,912
Upgrade
Change in Accounts Payable
-347.41-347.41-896.421,321-15,587-2,298
Upgrade
Change in Other Net Operating Assets
----0.59-8.93
Upgrade
Operating Cash Flow
336.31-427.63-317.52-749.96214.211,031
Upgrade
Operating Cash Flow Growth
-----79.23%-64.21%
Upgrade
Capital Expenditures
-57.67-61.71-99.74-48.12-171.63-301.73
Upgrade
Sale of Property, Plant & Equipment
164.61164.3352.251.5577.91,135
Upgrade
Divestitures
19.827.39.85-57.72-0.74
Upgrade
Investment in Securities
4.7----0.53-
Upgrade
Other Investing Activities
1010-0.550.04-
Upgrade
Investing Cash Flow
141.44139.92-37.64-46.02-36.51832.06
Upgrade
Short-Term Debt Issued
----127.64-
Upgrade
Long-Term Debt Issued
-0.1---10,572
Upgrade
Total Debt Issued
0.10.1--127.6410,572
Upgrade
Short-Term Debt Repaid
-----97.03-
Upgrade
Long-Term Debt Repaid
--0.1-72.71-94.95-48.66-11,419
Upgrade
Total Debt Repaid
-0.1-0.1-72.71-94.95-145.69-11,419
Upgrade
Net Debt Issued (Repaid)
-0-0-72.71-94.95-18.05-847.07
Upgrade
Issuance of Common Stock
----1,800-
Upgrade
Common Dividends Paid
----0.9-13.82-1,032
Upgrade
Dividends Paid
----0.9-13.82-1,032
Upgrade
Other Financing Activities
176.91174.81-48.14-21.010.252.77
Upgrade
Financing Cash Flow
176.91174.81-120.85-116.861,768-1,876
Upgrade
Foreign Exchange Rate Adjustments
-0-000-0.04-0.25
Upgrade
Net Cash Flow
654.66-112.91-476.01-912.841,946-13.13
Upgrade
Free Cash Flow
278.65-489.34-417.27-798.0842.58729.67
Upgrade
Free Cash Flow Growth
-----94.16%-69.71%
Upgrade
Free Cash Flow Margin
5.27%-9.43%-8.56%-19.09%1.03%13.48%
Upgrade
Free Cash Flow Per Share
0.02-0.03-0.04-0.060.000.05
Upgrade
Cash Interest Paid
--0.911.06--
Upgrade
Cash Income Tax Paid
295.08295.28211.36284.45235.31295.57
Upgrade
Levered Free Cash Flow
-6,2041,395-278.02117.24-6,02921,968
Upgrade
Unlevered Free Cash Flow
-6,2041,395-242.92166.55-5,39123,320
Upgrade
Change in Net Working Capital
6,575-1,067640.19-471.463,953-39,589
Upgrade
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.